 Department of Defense Department of the Air Force
Department of Army - USAMRAA
Department of Navy - Office of Naval Research
Department of Defense Department of the Air Force AFRL Kirtland AFB - Science, Innovation and Technology Partnership Intermediary Agreement Proposal Due Date: September 21, 2021 Expected Number of Awards: 1 Estimated Total Program Funding: $75,000,000 Award Ceiling: $55,000,000 Award Floor: Funding Opportunity Number: PIA-FOA-21-AFRL-0001 Purpose: The DoD Air Force Research Laboratory (AFRL) at Kirtland Air Force Base, New Mexico, is seeking applications under Funding Opportunity Announcement (FOA) entitled “Science, Innovation and Technology Partnership Intermediary Agreement”. The Government is seeking to enter into five-year Partnership Intermediary Agreements (PIAs) with entities that facilitate joint projects and accelerate technology transfer between the lab and the commercial market. These intermediaries help companies to identify federal technologies that can be licensed and commercialized. They also work to increase the likelihood of successful cooperative activities between the lab, small businesses, academia and industry. Under the future FOA, some the objectives will include, but may not be limited to:
https://www.grants.gov/web/grants/view-opportunity.html?oppId=333566 Department of Defense Department of the Army USAMRAA – DOD Melanoma, Discovery Award Pre-Application Submission Deadline: October 20, 2021 Proposal Due Date: November 10, 2021 Expected Number of Awards: 1 Estimated Total Program Funding: $3,200,000 Award Ceiling: Award Floor: Funding Opportunity Number: W81XWH-21-MRP-DA Purpose: The FY21 MRP Discovery Award supports innovative, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications in melanoma research. Studies supported by this award are expected to lay the groundwork for future avenues of scientific investigation regarding an important question for melanoma research and/or patient community. The proposed research project should include a well-formulated, testable hypothesis based on a sound scientific rationale and study design. Preliminary data are not required. If preliminary data is presented it will be evaluated for its support of the specific aims, objectives, and/or hypothesis. Innovation is a key characteristic of this funding opportunity. Innovative research may introduce a new paradigm, look at existing problems from new perspectives, or exhibit other highly creative qualities. Research that represents an incremental advancement on previously published work is not considered innovative. The following list, although not all-inclusive, provides examples of research that is not innovative:
Inclusion of preliminary data is not required but is allowed. The strength of the proposed research should be based on sound scientific rationale and logical reasoning. The presentation of substantial preliminary data suggests that the proposed research project would be more appropriately submitted to a different award mechanism. The outcome of research supported by this award should be the generation of robust preliminary data that can be used as a foundation for future research projects. Absence of preliminary data will not negatively affect scientific peer or programmatic review of the application. All data presented will be subject to evaluation. Early career investigators, including postdoctoral fellows (or equivalent), are encouraged to be named by the organization as the Principal Investigator (PI) on the application. https://www.grants.gov/web/grants/view-opportunity.html?oppId=335364 Department of Defense Department of the Army USAMRAA – DOD Neurofibromatosis, Clinical Trial Consortium Award Pre-Application Submission Deadline: September 17, 2021 Proposal Due Date: October 29, 2021 Expected Number of Awards: 1 Estimated Total Program Funding: $25,000,000 Award Ceiling: Award Floor: Funding Opportunity Number: W81XWH-21-NFRP-CTCA Purpose: The NFRP Clinical Trial Consortium Award mechanism was first offered in FY06, and subsequently in FY11 and FY16, with awards being made as grants or cooperative agreements. This FY21 research announcement is being offered through a different type of award mechanism, a Research Other Transaction Award (rOTA) under the authority of 10 USC 2371. The FY21 NFRP Clinical Trial Consortium Award is intended to support a major goal/product-driven consortium of exceptional institutions and investigators that will accelerate the clinical translation of basic NF research and ultimately decrease the impact of the disease. The objectives of the rOTA are the conception, design, development, and conduct of collaborative Phase I and II clinical evaluations of promising therapeutic agents for the management or treatment of NF1, NF2, and schwannomatosis. https://www.grants.gov/web/grants/view-opportunity.html?oppId=335360 Department of Defense Department of the Navy Office of Naval Research FY2022 Vannevar Bush Faculty Fellowship (VBFF) Program Proposal Due Date: February 4, 2022 Expected Number of Awards: 10 Estimated Total Program Funding: $24,000,000 Award Ceiling: $3,000,000 Award Floor: $0 Funding Opportunity Number: N00014-21-S-F007 Purpose: Before World War I, Dr. Vannevar Bush (1890-1974) was a professor and Dean of Engineering at the Massachusetts Institute of Technology and founded a large defense and electronics company. He was a forward-thinking policymaker who, during World War II, went on to serve as the director of the U.S. Defense Department’s Office of Scientific Research and Development, coordinating the work of thousands of scientists in the service of ending the war. In his 1945 report to the President of the United States, Science, “The Endless Frontier”, Bush called for an expansion of government support for science, and he pressed for the creation of the National Science Foundation (NSF). Dr. Bush was concerned about how the scientific research supported by the Department of Defense (DoD) during WWII could be sustained with a focus on peacetime goals. He believed that basic research was “the pacemaker of technological progress”. “New products and new processes do not appear full-grown”, Bush wrote. “They are founded on new principles and new conceptions, which in turn are painstakingly developed by research in the purest realms of science”. Dr. Bush’s life work embodies the spirit of this research program, formerly known as the National Security Science and Engineering Faculty Fellowship (NSSEFF). Therefore, in his in his honor, the name was changed to the Vannevar Bush Faculty Fellowship (VBFF) program (https://www.defense.gov/News/Article/Article/955536/dod-debuts-vannevar-bush-faculty-fellowship). Please see full opportunity announcement attached for additional information and instructions. https://www.grants.gov/web/grants/view-opportunity.html?oppId=335368 
0 Comments
Leave a Reply. |
AboutRFIs, Meeting Notices, Proposers/Industry Days, Nominations Archives
October 2021
Categories |
RSS Feed
